A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Clinical trial NCT06905873 · RECRUITING
Trial details
- NCT number
- NCT06905873
- Sponsor
- Forte Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-25
- Primary completion
- 2026-12-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.